Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Rossella De Luca"'
Autor:
Giuseppe Cicero, Raffaele Addeo, Rossella De Luca, Giuseppe Lo Re, Leonardo Gulotta, Pierenrico Marchesa, Gaspare Gulotta
Publikováno v:
Drugs in Context, Vol 9, Pp 1-8 (2020)
Background: TAS-102 is an oral monotherapy, combining trifluridine and tipiracil hydrochloride, indicated for the treatment of pretreated metastatic colorectal cancer (mCRC). The aim of this real-life study is to evaluate the efficacy and safety of T
Externí odkaz:
https://doaj.org/article/6d365768f7bf4631bc050095a0f52043
Autor:
Rossella De Luca
Publikováno v:
Philological Encounters. 6:470-503
This article focuses on the engagement of three scholars of the nineteenth century, later to be called scholars of the nahḍa, with an Arabic grammar manual titled Baḥth al-maṭālib wa-ḥathth al-ṭālib (“The Pursuit of the Questions and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::807dcbbfcbd3ca9edb6fd04274c0412a
https://doi.org/10.1163/24519197-bja10024
https://doi.org/10.1163/24519197-bja10024
Autor:
Cosimo Bruni, Martina Orlandi, Marco Maresca, Daniela Melchiorre, Rossella De Luca, Serena Guiducci, Amato de Paulis, Marco Matucci-Cerinic, Marta Dzhus, Gemma Lepri, Kamal Solanki, Yukai Wang, Alberto Moggi-Pignone, Silvia Bellando-Randone, Wanda Rossi
Publikováno v:
Rheumatology and Immunology Research. 2:113-119
In order to evaluate the importance of pain in systemic sclerosis (SSc), the characteristics of pain reported by patients with SSc were analyzed and compared with the characteristics of pain reported by patients with primary Sjőgren’s syndrome (pS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81ee7ff943434c6a1eafb8f9a97d271e
https://doi.org/10.2478/rir-2021-0015
https://doi.org/10.2478/rir-2021-0015
Publikováno v:
OncoTargets and Therapy. 12:1621-1627
Objective Metastatic breast cancer (MBC) is an incurable disease; the treatment of this disease prolongs survival, improving the quality of life (QoL) with a balance between efficacy and toxicity of the treatment. In recent years, treatment with nab-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2646abc2a1b30e6afcf00d7a7a83fd62
https://doi.org/10.2147/ott.s191519
https://doi.org/10.2147/ott.s191519
Autor:
Angela Salvato, Annunziata Auriemma, Gianluca Lo Coco, Alberto D’Agostino, Ornella Mistretta, Maria Stella Epifanio, Silvia Ileana Sara Fattoruso, Roberta Paci, Raffaele Addeo, Rossella De Luca, Giuseppe Cicero
Publikováno v:
World Journal of Oncology
Background: Metastatic colorectal cancer (mCRC) with wild type expression of RAS and RAF genes can be treated with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, such as cetuximab, in combination with chemotherapy. Skin toxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3940a5dac174c7ed15e9570aa0422261
https://pubmed.ncbi.nlm.nih.gov/34349854
https://pubmed.ncbi.nlm.nih.gov/34349854
Publikováno v:
Drug Design, Development and Therapy
Rossella De Luca,1 Livio Blasi,2 Massimiliano Alù,2 Valerio Gristina,1 Giuseppe Cicero1 1Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy; 2Medical Oncology Unit, ARNAS Hospita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64a8ffc9c2ff218393e4e3945cf4ca6b
https://doi.org/10.2147/dddt.s165851
https://doi.org/10.2147/dddt.s165851
Publikováno v:
OncoTargets and therapy
Giuseppe Cicero,1 Rossella De Luca,1 Francesco Dieli2 1Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy; 2Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76d6a68d250fe6c200c4f9d2869074f7
https://doi.org/10.2147/ott.s151276
https://doi.org/10.2147/ott.s151276
The Clinical Efficacy of Enzalutamide in Metastatic Prostate Cancer: Prospective Single-center Study
Publikováno v:
Anticancer Research. 37:1475-1480
Background/Aim: To evaluate the effectiveness of enzalutamide in Italian patients with hormone-refractory metastatic castration-resistant prostate cancer, progressing after chemotherapy with docetaxel plus prednisone. Patients and Methods: A total of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e9cd0430fd63cf03f7247ca49a9eb8
https://doi.org/10.21873/anticanres.11472
https://doi.org/10.21873/anticanres.11472
Autor:
Francesco Dieli, Angelo Cagnacci, Yuichiro Nakashima, Xavier Rivera, Monika Schmelz, Yoshinao Oda, Alessia Dalla Pria, Jonathan H. Schatz, Innocenza Palaia, Laura Cortesi, Nami Yamashita, Eiji Oki, Ira A. Oliff, Yu Nakaji, Alessia Romito, Marco Merli, Koji Ando, Oleksandr Halytskyy, Isabella Marchi, Elisabetta De Matteis, Lora Inclan, Hiroshi Saeki, Laura Vertechy, Satz Mengensatzproduktion, Shiraz Jamshaid, Hamid Hasson, Veronica Medici, Jose M. Guillen-Rodriguez, Caterina Uberti Foppa, Daniel O. Persky, Nasir Saleem, Giannina Contu, Yoko Zaitsu, Rossella De Luca, David J. Pinato, Angela Musella, Kizzy Parker, Francesca De Felice, Kara Heard, Rohini Sharma, Serena Maria Boccia, Yoshihiko Maehara, Masahiko Sugiyama, Anjeza Xholli, Giuseppe Cicero, Ludovico Muzii, Mark Bower, Soham D. Puvvada, Raya Saba, Koji Teraishi, Mark T. Nelson, Massimo Federico, Shinji Okano, Druckerei Stückle, Giovanni Grandi, Claudia Marchetti, Emanuela Messina, Violante Di Donato, Marco Monti, Nicole Pagani, Pierluigi Benedetti Panici, Yuichiro Umemoto, Angela Toss, Kippei Ohgaki
Publikováno v:
Oncology. 93:I-V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae87f17f8baaa03f121c8a8f3c51e79b
https://doi.org/10.1159/000481901
https://doi.org/10.1159/000481901
Publikováno v:
OncoTargets and therapy
Rossella De Luca,1 Giuseppe Profita,2 Giuseppe Cicero1 1Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy; 2Department of Surgical, Oncological and Oral Sciences, Section of Surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::92398f3cbcabaaedd881a421cf3c67b1
https://www.dovepress.com/nab-paclitaxel-in-pretreated-metastatic-breast-cancer-evaluation-of-ac-peer-reviewed-article-OTT
https://www.dovepress.com/nab-paclitaxel-in-pretreated-metastatic-breast-cancer-evaluation-of-ac-peer-reviewed-article-OTT